Mansoor M. Amiji

30.8k total citations · 7 hit papers
334 papers, 24.0k citations indexed

About

Mansoor M. Amiji is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Mansoor M. Amiji has authored 334 papers receiving a total of 24.0k indexed citations (citations by other indexed papers that have themselves been cited), including 180 papers in Molecular Biology, 108 papers in Biomaterials and 60 papers in Pharmaceutical Science. Recurrent topics in Mansoor M. Amiji's work include RNA Interference and Gene Delivery (133 papers), Nanoparticle-Based Drug Delivery (91 papers) and Advanced Drug Delivery Systems (56 papers). Mansoor M. Amiji is often cited by papers focused on RNA Interference and Gene Delivery (133 papers), Nanoparticle-Based Drug Delivery (91 papers) and Advanced Drug Delivery Systems (56 papers). Mansoor M. Amiji collaborates with scholars based in United States, Portugal and Saudi Arabia. Mansoor M. Amiji's co-authors include Srinivas Ganta, Harikrishna Devalapally, Aliasgar Shahiwala, Lara Milane, Lilian E. van Vlerken, Zhenfeng Duan, Tushar Vyas, Amit Singh, Dinesh B. Shenoy and Arun K. Iyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Mansoor M. Amiji

327 papers receiving 23.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A review of stimuli-responsive nanocarriers for drug and gene delivery

2008 1.8k citations Harikrishna Devalapally, Mansoor M. Amiji et al. Journal of Controlled Release profile →
Chitosan-based gastrointestinal delivery systems

2003 681 citations Mansoor M. Amiji et al. Journal of Controlled Release profile →
Exosome mediated communication within the tumor microenvironment

2015 585 citations Lara Milane, Mansoor M. Amiji et al. Journal of Controlled Release profile →
Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine

2015 454 citations Lara Milane, Mansoor M. Amiji et al. profile →
Technologies and Standardization in Research on Extracellular Vesicles

2020 361 citations Srujan Gandham, Angela L. Nocera et al. profile →
Local Immunomodulation Using an Adhesive Hydrogel Loaded with miRNA‐Laden Nanoparticles Promotes Wound Healing

2019 277 citations Mansoor M. Amiji et al. profile →
Strategies to reduce the risks of mRNA drug and vaccine toxicity

2024 105 citations Dimitrios Bitounis, Mansoor M. Amiji et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mansoor M. Amiji United States	86	10.1k	9.2k	6.1k	4.0k	2.3k	334	24.0k
Qiang Zhang China	76	9.4k 0.9×	7.5k 0.8×	6.1k 1.0×	2.8k 0.7×	2.0k 0.9×	402	19.2k
Véronique Préat Belgium	78	8.3k 0.8×	8.7k 0.9×	6.7k 1.1×	7.3k 1.8×	1.7k 0.7×	312	25.2k
W. Mark Saltzman United States	84	10.3k 1.0×	7.3k 0.8×	6.2k 1.0×	2.4k 0.6×	1.3k 0.6×	330	23.3k
Gert Storm Netherlands	95	13.2k 1.3×	12.6k 1.4×	9.9k 1.6×	2.5k 0.6×	3.3k 1.4×	441	30.9k
Kwangmeyung Kim South Korea	88	10.0k 1.0×	11.2k 1.2×	12.1k 2.0×	2.3k 0.6×	4.8k 2.0×	381	25.8k
Prashant Kesharwani India	76	8.0k 0.8×	6.6k 0.7×	5.5k 0.9×	3.3k 0.8×	2.4k 1.0×	568	20.2k
Zhirong Zhang China	75	8.2k 0.8×	6.0k 0.7×	5.3k 0.9×	3.4k 0.9×	1.5k 0.6×	525	19.1k
Vladimir P. Torchilin United States	72	9.9k 1.0×	11.9k 1.3×	7.9k 1.3×	2.1k 0.5×	2.7k 1.2×	257	21.9k
Stefaan C. De Smedt Belgium	94	13.8k 1.4×	7.9k 0.9×	10.0k 1.6×	2.5k 0.6×	5.1k 2.2×	475	31.6k
Vladimir P. Torchilin United States	71	17.0k 1.7×	15.8k 1.7×	9.8k 1.6×	3.3k 0.8×	3.3k 1.4×	185	31.7k

Countries citing papers authored by Mansoor M. Amiji

Since Specialization

Citations

This map shows the geographic impact of Mansoor M. Amiji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mansoor M. Amiji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mansoor M. Amiji more than expected).

Fields of papers citing papers by Mansoor M. Amiji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mansoor M. Amiji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mansoor M. Amiji. The network helps show where Mansoor M. Amiji may publish in the future.

Co-authorship network of co-authors of Mansoor M. Amiji

This figure shows the co-authorship network connecting the top 25 collaborators of Mansoor M. Amiji. A scholar is included among the top collaborators of Mansoor M. Amiji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mansoor M. Amiji. Mansoor M. Amiji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Cameron, et al.. (2025). Biodegradable polymeric microsphere formulations of full-length anti-VEGF antibody bevacizumab for sustained intraocular delivery. Drug Delivery and Translational Research. 15(9). 3149–3160. 1 indexed citations

Bailey, Keith, et al.. (2025). Treatment of Acute Liver Injury through Selective Tropism of High Mobility Group Box 1 Gene-Silenced Large Peritoneal Macrophages. ACS Nano. 19(12). 12102–12118. 2 indexed citations

Bitounis, Dimitrios & Mansoor M. Amiji. (2024). Lipid nanoparticles target haematopoietic stem cells. Nature Nanotechnology. 19(9). 1249–1250. 1 indexed citations

Li, Angela, et al.. (2024). Oral delivery of stabilized lipid nanoparticles for nucleic acid therapeutics. Drug Delivery and Translational Research. 15(5). 1755–1769. 11 indexed citations

Milane, Lara, et al.. (2023). Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant Breast Cancer. Journal of Controlled Release. 363. 435–451. 9 indexed citations

Francesco, Valentina Di, et al.. (2023). Nanotechnology-Enabled Topical Delivery of Therapeutics in Chronic Rhinosinusitis. Nanomedicine. 18(20). 1399–1415. 3 indexed citations

Parayath, Neha N., Srujan Gandham, & Mansoor M. Amiji. (2022). Tumor-Targeted miRNA Nanomedicine for Overcoming Challenges in Immunity and Therapeutic Resistance. Nanomedicine. 17(19). 1355–1373. 11 indexed citations

Gandham, Srujan, Husain Attarwala, & Mansoor M. Amiji. (2022). Mathematical Modeling and Experimental Validation of Extracellular Vesicle-Mediated Tumor Suppressor MicroRNA Delivery and Propagation in Ovarian Cancer Cells. Molecular Pharmaceutics. 19(11). 4067–4079. 2 indexed citations

Ganesh, Shanthi, et al.. (2021). Role of Vitronectin-Rich Protein Corona on Tumor-Specific siRNA Delivery and Transfection with Lipid Nanoparticles. Nanomedicine. 16(7). 535–551. 18 indexed citations

10.

Parayath, Neha N., Smrithi Padmakumar, & Mansoor M. Amiji. (2020). Extracellular vesicle-mediated nucleic acid transfer and reprogramming in the tumor microenvironment. Cancer Letters. 482. 33–43. 25 indexed citations

11.

Workman, Alan D., Angela L. Nocera, Dawei Wu, et al.. (2019). Discriminant analysis followed by unsupervised cluster analysis including exosomal cystatins predict presence of chronic rhinosinusitis, phenotype, and disease severity. International Forum of Allergy & Rhinology. 9(9). 1069–1076. 17 indexed citations

12.

Ahmad, Gulzar, Gerardo G. Mackenzie, James Egan, & Mansoor M. Amiji. (2019). DHA-SBT-1214 Taxoid Nanoemulsion and Anti–PD-L1 Antibody Combination Therapy Enhances Antitumor Efficacy in a Syngeneic Pancreatic Adenocarcinoma Model. Molecular Cancer Therapeutics. 18(11). 1961–1972. 16 indexed citations

13.

Parayath, Neha N., et al.. (2018). Direct CNS delivery of proteins using thermosensitive liposome-in-gel carrier by heterotopic mucosal engrafting. PLoS ONE. 13(12). e0208122–e0208122. 18 indexed citations

14.

Talekar, Meghna, et al.. (2015). Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian Cancer. Molecular Cancer Therapeutics. 14(7). 1521–1531. 44 indexed citations

15.

Amiji, Mansoor M., et al.. (2011). Label-free Raman Micro-Spectral Imaging of the Microenvironment of PANC-1 Spheroids. TechConnect Briefs. 3(2011). 364–366.

16.

Kriegel, Christina, et al.. (2009). Delivery strategies to enhance mucosal vaccination. Expert Opinion on Biological Therapy. 9(4). 427–440. 32 indexed citations

17.

Shah, Lipa, et al.. (2008). A model predicting delivery of saquinavir in nanoparticles to human monocyte/macrophage (Mo/Mac) cells. Biotechnology and Bioengineering. 101(5). 1072–1082. 22 indexed citations

18.

Vlerken, Lilian E. van & Mansoor M. Amiji. (2006). Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opinion on Drug Delivery. 3(2). 205–216. 271 indexed citations

19.

Amiji, Mansoor M., Curtis F. Crasto, Charles A. DiMarzio, et al.. (2005). Hetero-bifunctional Poly(ethylene glycol) Modified Gold Nanoparticles as an Intracellular Tracking and Delivery Agent. TechConnect Briefs. 1(2005). 324–327. 2 indexed citations

20.

Li, Jane, Curtis F. Crasto, Mansoor M. Amiji, et al.. (2005). An approach to heterobifunctional poly(ethyleneglycol) bioconjugates. Bioorganic & Medicinal Chemistry Letters. 15(24). 5558–5561. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact